Organogenesis Holdings Inc.

ORGO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$1$5$16$95
Dep. & Amort.$17$23$11$17
Deferred Tax-$11$2$2-$32
Stock-Based Comp.$11$9$7$4
Change in WC-$49-$18-$34-$39
Other Non-Cash$45$10$24$18
Operating Cash Flow$14$31$25$62
Investing Activities
PP&E Inv.-$10-$24-$34-$31
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$10-$24-$34-$31
Financing Activities
Debt Repay.-$68-$5-$3-$2
Stock Issued$0$0$0$2
Stock Repurch.-$25$0$0$0
Dividends Paid-$2$0$0$0
Other Fin. Act.$123-$0$1-$1
Financing Cash Flow$28-$6-$2-$1
Forex Effect$0$0$0$0
Net Chg. in Cash$32$1-$11$30
Supplemental Information
Beg. Cash$104$103$115$85
End Cash$136$104$103$115
Free Cash Flow$4$7-$9$31
Organogenesis Holdings Inc. (ORGO) Financial Statements & Key Stats | AlphaPilot